Frank Ruffo has sold ACRS and made no open-market buys since Apr 2021
CFO at Aclaris Therapeutics, Inc.
SEC CIK 0001654450 · Filings on SEC.gov ↗
$0Bought
$2.8MSold
NoneLast buy
Every filing
3 filings since Apr 2021, newest first
Filings come from SEC EDGAR. Not investment advice.